


Ask a doctor about a prescription for METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION
Package Leaflet: Information for the User
Metoclopramide Kern Pharma 1 mg/ml Oral Solution EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack:
Metoclopramide Kern Pharma is an antiemetic. It contains the active substance metoclopramide. It acts on an area of the brain that prevents nausea or vomiting.
Adult population
Metoclopramide Kern Pharma is used in adults:
Metoclopramide can be taken in combination with oral painkillers in the case of migraine to make the painkillers more effective.
Pediatric population
Metoclopramide Kern Pharma is indicated in children (1-18 years of age) if other treatments do not work or cannot be used to prevent delayed nausea and vomiting that may occur after chemotherapy.
Do not take Metoclopramide Kern Pharma
(pheochromocytoma),
Do not give Metoclopramide Kern Pharma to children under 1 year of age (see below “Children and adolescents”).
Do not take Metoclopramide Kern Pharma if any of the above applies to you. If you are not sure, consult your doctor, pharmacist, or nurse before taking this medicine.
Warnings and precautions
Consult your doctor, pharmacist, or nurse before taking Metoclopramide Kern Pharma if:
Your doctor may perform blood tests to check your blood pigment levels. In cases of abnormal levels (methemoglobinemia), treatment should be discontinued immediately and permanently.
You should wait at least 6 hours between each dose of metoclopramide, even in the case of vomiting or rejection of the dose, to avoid overdose.
Do not exceed 3 months of treatment due to the risk of involuntary muscle spasms.
Children and adolescents
Uncontrollable movements (extrapyramidal disorders) may occur in children and young adults.
This medicine should not be used in children under 1 year of age due to the high risk of uncontrollable movements (see above “Do not take Metoclopramide Kern Pharma”).
Using Metoclopramide Kern Pharma with other medicines
Tell your doctor, pharmacist, or nurse if you are taking, have recently taken, or might take any other medicines. This is because some medicines may affect the way metoclopramide works or metoclopramide may affect the way other medicines work. These medicines include:
Taking Metoclopramide Kern Pharma with food, drink, and alcohol
Do not consume alcohol during treatment with metoclopramide because it increases the sedative effect of Metoclopramide Kern Pharma.
Pregnancy and breastfeeding
If you are pregnant, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Metoclopramide Kern Pharma may be taken during pregnancy if necessary. Your doctor will decide whether or not to administer this medicine.
Metoclopramide Kern Pharma is not recommended during breastfeeding because metoclopramide passes into breast milk and may affect your baby.
Driving and using machines
After taking Metoclopramide Kern Pharma, you may feel drowsy, dizzy, or have uncontrollable movements, such as tics, twitches, or muscle contractions, which can affect your vision and interfere with your ability to drive and use machines.
Metoclopramide Kern Pharma contains propyl parahydroxybenzoate and methyl parahydroxybenzoate
It may cause allergic reactions (possibly delayed) because it contains propyl parahydroxybenzoate (E-216) and methyl parahydroxybenzoate (E-218).
Follow exactly the administration instructions of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again.
All indications (adult patients)
A single dose of 10 mg is recommended, which can be repeated up to three times a day.
The maximum recommended daily dose is 30 mg or 0.5 mg/kg body weight.
The maximum treatment duration is 5 days.
To prevent delayed nausea and vomiting that may occur after chemotherapy (children 1-18 years of age)
The recommended dose is 0.1 to 0.15 mg/kg body weight, which can be repeated up to three times a day, taken orally.
The maximum dose in 24 hours is 0.5 mg/kg body weight.
Dosing Table
Age | Body weight | Dose | Frequency |
1 – 3 years | 10-14 kg | 1 mg (equal to 1ml) | Up to 3 times a day |
3 – 5 years | 15-19 kg | 2 mg (equal to 2ml) | Up to 3 times a day |
5 – 9 years | 20-29 kg | 2.5 mg (equal to 2.5 ml) | Up to 3 times a day |
9 – 18 years | 30-60 kg | 5 mg (equal to 5 ml) | Up to 3 times a day |
15 – 18 years | Over 60 kg | 10 mg (equal to 10 ml) | Up to 3 times a day |
Use the dosing cap included in the package of the oral solution to administer the correct dose of metoclopramide.
The dosing cap is graduated in ml. The correspondence with body weight is detailed in the dosing table.
Do not take this medicine for more than 5 days to prevent delayed nausea and vomiting that may occur after chemotherapy.
Method of administration
Metoclopramide Kern Pharma is administered orally.
You should wait at least 6 hours between each dose of metoclopramide, even in the case of vomiting or rejection of the dose, to avoid overdose.
Elderly population
The dose may need to be reduced depending on kidney problems, liver problems, and general health problems.
Adults with kidney problems
Tell your doctor if you have kidney problems. The dose should be reduced if you have moderate to severe kidney problems.
Adults with liver problems
Tell your doctor if you have liver problems. The dose should be reduced if you have severe liver problems.
Children and adolescents
Metoclopramide should not be used in children under 1 year of age (see section 2).
If you take more Metoclopramide Kern Pharma than you should
Contact your doctor or pharmacist immediately. You may experience uncontrollable movements (extrapyramidal disorders), drowsiness, some consciousness problems, confusion, hallucinations, and heart problems. Your doctor may prescribe a treatment for these effects if necessary.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.
If you forget to take Metoclopramide Kern Pharma
Do not take a double dose to make up for forgotten doses.
If you have any further questions on the use of this medicine, ask your doctor, nurse, or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop the treatment and inform your doctor, pharmacist, or nurse immediately if
you experience one of the following signs while taking this medicine:
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Uncommon(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1,000 people)
Frequency not known(frequency cannot be estimated from the available data)
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines and Health Products Agency (AEMPS) website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
No special storage conditions are required.
Do not use Metoclopramide Kern Pharma after the expiry date stated on the packaging and on the bottle. The expiry date is the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Return the packaging and any unused medicine to a pharmacy. If you are unsure, ask your pharmacist how to dispose of the packaging and any unused medicine. This will help protect the environment.
Composition of Metoclopramide Kern Pharma 1 mg/ml Oral Solution
Appearance of the product and packaging contents
Metoclopramide Kern Pharma is a solution packaged in a 250 ml topaz-colored plastic bottle with a 10 ml dosing cap for oral administration.
Marketing authorization holder and manufacturer
Kern Pharma, S.L.
Pol. Ind. Colón II, C/Venus 72,
08228 Terrassa (Barcelona)
Spain
Date of last revision of this leaflet: November 2019
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION in November, 2025 is around 2.5 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for METOCLOPRAMIDE KERN PHARMA 1 mg/ml ORAL SOLUTION – subject to medical assessment and local rules.